Biology Reference
In-Depth Information
Yirmiya R, editors. Cytokines, stress and depression. New York: Plenum Press; 1999.
p. 283-316.
88. Anisman H, Kokkinidis L, Borowski T, Merali Z. Differential effects of interleukin
(IL)-1 beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation.
Brain Res 1998;779:177-87.
89. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res
1996;711:163-74.
90. De La Garza R, Fabrizio KR, Radoi GE, Vlad T, Asnis GM. The non-steroidal anti-in-
flammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations in
reward behavior and corticosterone release. Behav Brain Res 2003;149:77-85.
91. Maier SF, Nguyen KT, Deak T, Milligan ED, Watkins LR. Stress, learned helplessness
and brain interleukin-1. In: Dantzer R, Wollmann EE, Yirmiya R, editors. Cytokines,
stress and depression. New York: Plenum Press; 1999. p. 235-50.
92. Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus JJ. Depression-
related disturbances in mitogen-induced lymphocyte responses and interleukin-1 and
soluble interleukin-2 receptor production. Acta Psychiatr Scand 1991;84:379-86.
93. Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E. Interleukin 1: a putative mediator
of HPA axis hyperactivity in major depression. Am J Psychiatry 1993;150:1189-93.
94. Nassberger L, Traskman-Bendz L. Increased soluble interleukin-2 receptor concentra-
tions in suicide attempters. Acta Psychiatr Scand 1993;88:48-52.
95. Maes M, Meltzer H, Bosmans E, Bergmans R, Van Doolaeghe E, Rajan R, et al.
Increased plasma concentrations of interleukin-6, soluble interleukin-6 receptor, solu-
ble interleukin-2 receptor and transferrin receptor in major depression. J Affect Disord
1995;34:301-9.
96. Sluzewska A, Rybakowski JK, Sobieska M, Bosmans E, Pollet H, Wiktorwicz K.
Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression.
Depression 1996;39:149-55.
97. Kubera M, Maes M. Serotonin-immune interactions in major depression. In: Patterson P,
Kordon C, Christen Y, editors. Neuro-immune interactions in neurologic and psychiatric
disorders. Berlin: Springer Verlag; 2000. p. 79-87.
98. Jozuka H, Jozuka E, Takeuchi S, Nishikaze O. Comparison of immunological and endo-
crinological markers associated with major depression. J Int Med Res 2003;31:36-41.
99. Maes M, Scharpe S, Bosmans E, Vanderwoude M, Suy E, Calabrese J, et al. Relationship
between interleukin-6 activity, acute phase proteins and function of the hypothalamic--
pituitary adrenal axis in severe depression. Psychiatry Res 1993;49:11-27.
100. Maes M, Bosmans E, Meltzer HY. Immunoendocrine aspects of major depression.
Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin
and cortisol. Eur Arch Psychiatry Clin Neurosci 1995;245:172-78.
101. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schild A, et al. Plasma levels of
cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission:
effects of confounding factors and diagnosis. J Psychiatr Res 1999;33:407-18.
102. Carpenter LL, Heninger GR, Malison RT, Tyrka AR, Price LH. Cerebrospinal fluid inter-
leukin (IL)-6 in unipolar major depression. J Affect Disord 2004;79:285-89.
103. Dantzer R, Wollmann E, Vitkovic L, Yirmiya R. Cytokines and major depression. Mol
Psychiatry 1999;4:328-32.
104. Kronfol Z, Singh VJ, Zhang Q. Plasma cytokines, acute phase proteins and cortisol in
major depression. Biol Psychiatry 1995;37:609A.
105. Kronfol Z, House JD. Lymphocyte mitogenesis, immunoglobulin and complement levels
in depressed patients and normal controls. Acta Psychiatr Scand 1989;80:142-67.
